1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

TABLE 4: Clinical information for 72 patients with intra-axial lesions
Information Neurodegenerative (n = 72) Leukoencephalopathy-like (n = 46)^* Vascular Pattern (n = 8)^*
Age at diagnosis of LCH 
 Mean 2 y 4 mo 2 y 8 mo 3 y 1 mo
 Range birth to 40 y birth to 40 y 1 y 5 mo to 20 y
Age at diagnosis of CNS disease 
 Mean 9 y 13 y 4 mo 13 y
 Range 2 y 4 mo to 52 y 2 to 47 y 3 to 22 y
Chemotherapy before CNS disease 
 No. of patients 62 32 6
 Mean age 2 y 4 mo 2 y 8 mo 2 y
 Age range 3 to 40 y 6 mo to 40 y 1 y 5 mo to 5 y 3 mo
Cranial radiotherapy before CNS disease 
 No. of patients 15 9 1
 Mean age 3 y 7 mo 5 y 6 mo 1 y 5 mo
 Age range 1 y 5 mo to 27 y 2 y 7 mo to 28 y Not applicable
Neurologic symptoms 
 None 18 17 0
 Subtle 15 6 0
 Severe 39 23 8
Observation time 
 Mean 8 y 3 mo 8 y 6 mo 10 y 7 mo
 Range 1 mo to 20 y 1 mo to 20 y 3 to 17 y
* All patients had additional neurodegenerative lesions.